5 Biotech Penny Stocks Smart Money Is Piling On
Apart from technology, if there ever was a sector that short sellers were afraid to touch for fear of being squeezed out vehemently, it has to be biotech...
Posts Tagged ‘Navidea Biopharmaceuticals Inc. (NAVB)’
Platinum Partners to Shut Down Main Fund; Here Are Its 5 Stock Picks
Platinum Partners, the New York-based hedge fund that is in the midst of two investigations, recently informed its investors that it will be liquidating...
Immersion, Navidea Biopharmaceuticals & More Picks From This $58 Billion Hedge Fund Company
Every quarter, many money managers have to disclose what they’ve bought and sold via “13F” filings. Their latest moves can shine a bright...
Here is What Hedge Funds Think About Syneron Medical Ltd. (ELOS)
Is it smart to be bullish on Syneron Medical Ltd. (NASDAQ:ELOS)? Now, according to many investors, hedge funds are viewed as delayed, outdated investment...
Hedge Funds Are Selling Accuray Incorporated (ARAY)
If you were to ask many investors, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times. Although there...
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): The Five Most Misdiagnosed Diseases
There’s little denying that the technological, research, and medicinal aspects of patient care are improving at breakneck speed. But sometimes,...
Amarin Corporation plc (ADR) (AMRN), Achillion Pharmaceuticals, Inc. (ACHN): Three Biotech Stocks That Could Double by Next Summer
Babe Ruth wasn’t afraid to swing for the fences. That’s how he became Major League Baseball’s home run king for decades. If you’...
Exactech, Inc. (EXAC): Are Hedge Funds Right About This Stock?
Is Exactech, Inc. (NASDAQ:EXAC) a buy right now? Money managers are becoming more confident. The number of long hedge fund positions increased by 2 in...
Is PhotoMedex Inc (PHMD) Going to Burn These Hedge Funds?
Is PhotoMedex Inc (NASDAQ:PHMD) a buy, sell, or hold? The best stock pickers are taking a bullish view. The number of long hedge fund positions advanced...
Should You Buy Palomar Medical Technologies Inc (PMTI)?
Palomar Medical Technologies Inc (NASDAQ:PMTI) investors should be aware of an increase in hedge fund interest lately. To most market participants, hedge...
Accuray Incorporated (ARAY): Insiders Are Buying, Should You?
Accuray Incorporated (NASDAQ:ARAY) was in 17 hedge funds’ portfolio at the end of the first quarter of 2013. ARAY has seen an increase in hedge...
Myriad Genetics, Inc. (MYGN), Roche Holding Ltd. (ROG): Angelina Jolie’s Selfless Act Heightens Breast Cancer Awareness
I admit to not being a big fan of many of her movies — possibly the only man on the planet who will admit so — but there’s little denying...
Intel Corporation (INTC) & More: $67 Million Equity Portfolio’s Favorites Might Surprise You
Platinum Management is the hedge fund run by Mark Nordlicht, and is part of the $1 billion Platinum Partners fund. Platinum manages a rather small, $67...
ZIOPHARM Oncology Inc. (ZIOP), Ariad Pharmaceuticals, Inc. (ARIA): 3 Reasons Investors Are Scared of Biotech Stocks
Biotechs offer the possibility of monster returns. Overnight doubles aren’t out of the question. Triples and quadruples as a drug successfully progresses...
Bazaarvoice Inc. (BV), Heckmann Corporation (HEK), MEMC Electronic Materials, Inc. (WFR): 5 Stocks Under $10 Worth Buying
If you’ve got 10 bucks, I have some stock ideas for you. I’ve been singling out attractive opportunities in low-priced stocks since my original...
Only One of These Stocks Won’t Be a Winner: LDK Solar Co., Ltd (ADR) (LDK), Navidea Biopharmaceuticals Inc (NAVB) and More
Ten days and counting. The Dow Jones Industrial Average added to its string of consecutive days moving higher, notching another 83-point gain to close...
This Week in Biotech: Navidea Biopharmaceuticals Inc (NAVB), Sinovac Biotech Ltd. (SVA) and More
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it’s evident that investment dollars are willingly...
Down 12%: Navidea Biopharmaceuticals Inc. (NAVB)’s Post-Approval Plunge – Eli Lilly & Co. (LLY), Cardinal Health, Inc. (CAH)
Navidea Biopharmaceuticals Inc. (NYSEMKT:NAVB) is experiencing a case of “sell the news” today. The company got a mid-day Food and Drug Administration...
Tackling Cancer: Breast Cancer’s Biggest Current & Upcoming Players – Roche Holding Ltd. (ADR) (RHHBY), AstraZeneca plc (ADR) (AZN), ImmunoGen, Inc. (IMGN)
As I noted two weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
Are Short Sellers On to Something at Navidea Biopharmaceuticals Inc (NAVB)? – Cardinal Health, Inc. (CAH)
Since everyone loves a winner, it’s reasonable to assume that everyone hates a loser — everyone but short sellers, at least. These contrarian...
